August 25, 2007 - Toronto, Canada Interface Biologics Inc., Toronto, Ontario is very pleased to announce the addition of Dr. Nicolas Chronos, M. D. to its Advisory Board.
Dr. Chronos is the Chief Medical and Scientific Officer of the Saint Joseph's Research Institute (SJRI) at Saint Joseph's Hospital, Atlanta, where he directs and oversees pre-clinical and clinical research. He is a practising Interventional Cardiologist for the Atlanta Cardiology Group (at Saint Joseph's Hospital of Atlanta), and an Adjunct Professor of Cardiology and Medicine at Duke University.
"We were very pleased when Dr. Chronos agreed to serve on our Advisory Board. His vast knowledge of research topics plus being a practicing cardiologist will be of great value not only to our drug eluting stent program, but to the company's entire portfolio of product platforms," said Rich Sullivan, President and CEO.
Interface Biologics Inc. (IBI) is a privately held biomaterials company located in Toronto, Canada. The company develops and markets cutting edge polymer technologies that are programmed at the nano level for the combination medical device marketplace. For more information contact, Mark Steedman, Director, Business Development (416) 673 8158 or www.interfacebiologics.com